These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15256439)

  • 1. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer.
    Kwabi-Addo B; Wang J; Erdem H; Vaid A; Castro P; Ayala G; Ittmann M
    Cancer Res; 2004 Jul; 64(14):4728-35. PubMed ID: 15256439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer.
    Wang J; Thompson B; Ren C; Ittmann M; Kwabi-Addo B
    Prostate; 2006 May; 66(6):613-24. PubMed ID: 16388505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of fibroblast growth factors and their receptors in prostate cancer.
    Kwabi-Addo B; Ozen M; Ittmann M
    Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
    Shain SA
    Mol Cancer Res; 2004 Nov; 2(11):653-61. PubMed ID: 15561781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.
    Ropiquet F; Giri D; Kwabi-Addo B; Mansukhani A; Ittmann M
    Cancer Res; 2000 Aug; 60(15):4245-50. PubMed ID: 10945637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
    Giri D; Ropiquet F; Ittmann M
    Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
    Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
    Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
    Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P
    Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors.
    Jin C; Wang F; Wu X; Yu C; Luo Y; McKeehan WL
    Cancer Res; 2004 Jul; 64(13):4555-62. PubMed ID: 15231666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma.
    Fritzsche S; Kenzelmann M; Hoffmann MJ; Müller M; Engers R; Gröne HJ; Schulz WA
    Endocr Relat Cancer; 2006 Sep; 13(3):839-49. PubMed ID: 16954433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 17 is over-expressed in human prostate cancer.
    Heer R; Douglas D; Mathers ME; Robson CN; Leung HY
    J Pathol; 2004 Dec; 204(5):578-86. PubMed ID: 15538740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate.
    Ittman M; Mansukhani A
    J Urol; 1997 Jan; 157(1):351-6. PubMed ID: 8976296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation.
    Shain SA; Sarić T; Ke LD; Nannen D; Yoas S
    Cell Growth Differ; 1996 May; 7(5):573-86. PubMed ID: 8732667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions.
    Kornmann M; Ishiwata T; Beger HG; Korc M
    Oncogene; 1997 Sep; 15(12):1417-24. PubMed ID: 9333017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant fibroblast growth factor receptor signaling in bladder and other cancers.
    Chaffer CL; Dopheide B; Savagner P; Thompson EW; Williams ED
    Differentiation; 2007 Nov; 75(9):831-42. PubMed ID: 17697126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation.
    Rosini P; Bonaccorsi L; Baldi E; Chiasserini C; Forti G; De Chiara G; Lucibello M; Mongiat M; Iozzo RV; Garaci E; Cozzolino F; Torcia MG
    Prostate; 2002 Dec; 53(4):310-21. PubMed ID: 12430142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
    Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
    Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
    Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
    Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of bone morphogenetic protein-7 (BMP-7) in human prostate.
    Masuda H; Fukabori Y; Nakano K; Shimizu N; Yamanaka H
    Prostate; 2004 Apr; 59(1):101-6. PubMed ID: 14991870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.
    Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z
    Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.